185 related articles for article (PubMed ID: 36288286)
1. Up-regulation of BTN3A1 on CD14
Zhou J; Zhang J; Tao L; Peng K; Zhang Q; Yan K; Luan J; Pan J; Su X; Sun J; Zhang Z; Shen L
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2117523119. PubMed ID: 36288286
[TBL] [Abstract][Full Text] [Related]
2. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
[TBL] [Abstract][Full Text] [Related]
3. Elevated Expressions of BTN3A1 and RhoB in Psoriasis Vulgaris Lesions by an Immunohistochemical Study.
Tian Z; Wong W; Wu Q; Zhou J; Yan K; Chen J; Zhang Z
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):119-125. PubMed ID: 34545848
[TBL] [Abstract][Full Text] [Related]
4. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
[TBL] [Abstract][Full Text] [Related]
5. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
6. A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1.
Mattarei A; Enzinger M; Gu S; Karunakaran MM; Kimmel B; Berner N; Adams EJ; Herrmann T; Amslinger S
Chemistry; 2017 Sep; 23(49):11945-11954. PubMed ID: 28631855
[TBL] [Abstract][Full Text] [Related]
7. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
[TBL] [Abstract][Full Text] [Related]
8. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
[TBL] [Abstract][Full Text] [Related]
9. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
[TBL] [Abstract][Full Text] [Related]
10. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
[TBL] [Abstract][Full Text] [Related]
11. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
[TBL] [Abstract][Full Text] [Related]
12. RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor.
Sebestyen Z; Scheper W; Vyborova A; Gu S; Rychnavska Z; Schiffler M; Cleven A; Chéneau C; van Noorden M; Peigné CM; Olive D; Lebbink RJ; Oostvogels R; Mutis T; Schuurhuis GJ; Adams EJ; Scotet E; Kuball J
Cell Rep; 2016 May; 15(9):1973-85. PubMed ID: 27210746
[TBL] [Abstract][Full Text] [Related]
13. Expression level of BTN3A1 on the surface of CD14
Tomogane M; Omura M; Sano Y; Shimizu D; Toda Y; Hosogi S; Kimura S; Ashihara E
Biochem Biophys Res Commun; 2022 Jan; 588():47-54. PubMed ID: 34952469
[TBL] [Abstract][Full Text] [Related]
14. Vγ9Vδ2 TCR-activation by phosphorylated antigens requires butyrophilin 3 A1 (BTN3A1) and additional genes on human chromosome 6.
Riaño F; Karunakaran MM; Starick L; Li J; Scholz CJ; Kunzmann V; Olive D; Amslinger S; Herrmann T
Eur J Immunol; 2014 Sep; 44(9):2571-6. PubMed ID: 24890657
[TBL] [Abstract][Full Text] [Related]
15. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
[TBL] [Abstract][Full Text] [Related]
16. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.
Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ
Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779
[TBL] [Abstract][Full Text] [Related]
17. B7H3-targeting chimeric antigen receptor modification enhances antitumor effect of Vγ9Vδ2 T cells in glioblastoma.
Wang Y; Ji N; Zhang Y; Chu J; Pan C; Zhang P; Ma W; Zhang X; Xi JJ; Chen M; Zhang Y; Zhang L; Sun T
J Transl Med; 2023 Sep; 21(1):672. PubMed ID: 37770968
[TBL] [Abstract][Full Text] [Related]
18. Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
Boutin L; Scotet E
Front Immunol; 2018; 9():828. PubMed ID: 29731756
[TBL] [Abstract][Full Text] [Related]
19. Ligand-induced interactions between butyrophilin 2A1 and 3A1 internal domains in the HMBPP receptor complex.
Hsiao CC; Nguyen K; Jin Y; Vinogradova O; Wiemer AJ
Cell Chem Biol; 2022 Jun; 29(6):985-995.e5. PubMed ID: 35081362
[TBL] [Abstract][Full Text] [Related]
20. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
